CME Group
Brendan Davis serves as a Corporate Development Manager on the Corporate Transactions Team at CME Group since October 2020, where responsibilities include evaluating and executing mergers, acquisitions, and complex commercial opportunities, alongside deal valuation and negotiation. Concurrently, Brendan holds the position of Senior Corporate Development Analyst at FAN4Kids. Prior experience includes serving as a Director at Morgan Stanley from June 2016 to September 2019, where support was provided to the COO and Director of Finance & Strategy at NY Presbyterian Morgan Stanley Children's Hospital through corporate development and financial planning. Brendan began the professional career as an Investment Banking Analyst. Currently enrolled in the MBA program at Columbia Business School (2022 - 2024), Brendan holds a Bachelor of Business Administration in Finance from Bucknell University (2012 - 2015).
This person is not in any teams
This person is not in any offices
CME Group
26 followers
As the world's leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. CME Group exchanges offer the widest range of global benchmark products across all major asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate. CME Group brings buyers and sellers together through its CME Globex® electronic trading platform and its trading facilities in New York and Chicago. CME Group also operates CME Clearing, one of the world’s leading central counterparty clearing provider in the world, which offers clearing and settlement services for exchange-traded contracts, as well as for over-the-counter derivatives transactions through CME ClearPort®. These products and services ensure that businesses everywhere can substantially mitigate counterparty credit risk in both listed and over-the-counter derivatives markets.